Results 281 to 290 of about 162,915 (338)

Computed tomography-based radiomics modeling to predict patient overall survival in cervical cancer with intensity-modulated radiotherapy combined with concurrent chemotherapy. [PDF]

J Int Med Res
Xiao L, Wang Y, Shi X, Pang H, Li Y.
europepmc   +1 more source

Diagnostic and prognostic value of coagulation markers and platelet-derived growth factor-BB in evaluating intensity-modulated radiotherapy efficacy in nasopharyngeal carcinoma. [PDF]

Am J Cancer Res
Zhang H, Ye D.
europepmc   +1 more source

Remarkable Response to Radiotherapy With Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Lymphoepithelial Carcinoma of the Hypopharynx in a Nonagenarian. [PDF]

Cureus
Katano A, Sawayanagi S, Yamashita H.
europepmc   +1 more source

The dosimetric value and safety evaluation of 3D printed bolus in adjuvant intensity-modulated radiotherapy after radical mastectomy for breast cancer: a prospective cohort study. [PDF]

Radiat Oncol
Wang Y, Li H, Hu W, Li B, Du Y, Li F.
europepmc   +1 more source

Efficacy and safety of simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative chemotherapy treatment of multifocal high-grade glioma. [PDF]

Front Oncol
Jiang N, Xu LP, Li F, Wang PP, Cao Y.
europepmc   +1 more source

Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis. [PDF]

Cancers (Basel)
Loap P, Uakkas A, Allali S, Bouziane J, Fourquet A, Kirova Y.   +5 more
europepmc   +1 more source

Hypofractionated and intensity-modulated radiotherapy combined with systemic therapy in metastatic hepatocellular carcinoma: A case report. [PDF]

World J Clin Oncol
Chen QQ, Chen CQ, Liu JK, Huang MY, Pan M, Huang H.   +5 more
europepmc   +1 more source

Exploration of the value of concurrent chemotherapy for T2N1 nasopharyngeal carcinoma under intensity modulated radiotherapy mode. [PDF]

Front Oncol
Liao K, Zhang J, Qiu W, Zheng R.
europepmc   +1 more source

Whole-Brain Radiotherapy Simultaneous Integrated Boost Intensity-Modulated Radiotherapy Combined With Anlotinib in the Treatment of Brain Metastases. [PDF]

Cancer Control
Tao W, Jiang C, Xie J, Liu W, Wang S, Zhang J, Qiao X, Yu J, Jia T, Cao Y.   +9 more
europepmc   +1 more source

Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy. [PDF]

Cancer Manag Res
Tang L, Li X, Wang Y, Tong Y.
europepmc   +1 more source